Display options
Share it on

J Ophthalmic Vis Res. 2013 Jul;8(3):237-43.

Rate of Post-traumatic Endophthalmitis with or without Injection of Balanced Salt Solution.

Journal of ophthalmic & vision research

Nasrin Rafati, Mohsen Azarmina, Farid Zaeri, Shahin Yazdani, Roham Soheilian, Masoud Soheilian

Affiliations

  1. Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  2. Department of Biostatistics, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  3. Medical Student, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

PMID: 24349667 PMCID: PMC3853788

Abstract

PURPOSE: In a study complementing a previous multicenter randomized clinical trial on prophylactic injection of intraocular antibiotics during primary repair of penetrating eye injuries (PEIs), we sought to determine whether needle entrance and injection of balanced salt solution (BSS), per se, could increase the rate of acute post-traumatic bacterial endophthalmitis (APBE).

METHODS: Patients randomized to the BSS injection arm (n=167) of the Traumatic Endophthalmitis Trial, and eligible patients who had refused enrollment and received no intraocular injections during primary repair (n=111) were compared for the development of APBE.

RESULTS: APBE occurred in 8 of 167 (4.8%) eyes in the BSS group and in 5 of 111 (4.5%) eyes in the non-injection group (P=0.91). Retained intraocular foreign bodies were present in 46 eyes including 25 (15%) eyes in the BSS injection group and 21 (18.9%) eyes in the non-injection group (P=0.38). Logistic regression analysis showed no significant difference between BSS injected and non-injected eyes in terms of APBE (P=0.69). However, the presence of intraocular foreign bodies was strongly associated with the risk of endophthalmitis (P<0.001, OR=14.1, 95% CI: 4.1-48.5).

CONCLUSION: Needle entrance and intraocular injection of BSS during primary repair of PEIs does not increase the risk of APBE.

Keywords: Bacterial Endophthalmitis; Intraocular Injection; Penetrating Eye Injury

References

  1. Am J Ophthalmol. 2008 May;145(5):879-82 - PubMed
  2. Arch Ophthalmol. 2007 Apr;125(4):460-5 - PubMed
  3. Retina. 2004 Oct;24(5):676-98 - PubMed
  4. Ophthalmology. 1989 Dec;96(12):1722-6 - PubMed
  5. Bull Med Ethics. 2000 May;(158):9-11 - PubMed
  6. Compr Ophthalmol Update. 2006 Nov-Dec;7(6):277-84; discussion 285-6 - PubMed
  7. Retina. 2004 Oct;24(5 Suppl):S3-19 - PubMed
  8. Ophthalmology. 1998 Aug;105(8):1404-10 - PubMed
  9. Retina. 2004 Oct;24(5):699-705 - PubMed
  10. Indian J Ophthalmol. 2008 Sep-Oct;56(5):403-7 - PubMed
  11. Arch Ophthalmol. 2008 May;126(5):742-3; author reply 743-4 - PubMed
  12. Am J Ophthalmol. 1995 Sep;120(3):376-85 - PubMed
  13. Arch Ophthalmol. 1989 Dec;107(12):1767-72 - PubMed
  14. Indian J Ophthalmol. 2003 Mar;51(1):39-44 - PubMed
  15. Ophthalmologica. 1996;210(6):329-35 - PubMed
  16. Arch Ophthalmol. 1990 Jun;108(6):857-60 - PubMed
  17. Expert Opin Pharmacother. 2009 Sep;10(13):2119-26 - PubMed
  18. Int Ophthalmol. 2001;24(6):323-30 - PubMed
  19. J Cataract Refract Surg. 2008 Sep;34(9):1451-9 - PubMed
  20. Retina. 2003 Oct;23(5):686-91 - PubMed
  21. Ophthalmology. 2004 Nov;111(11):2015-22 - PubMed

Publication Types